PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
Eplerenone (Inspra, Pfizer) improves the prognosis of patients with chronic heart failure and heart failure after acute myocardial infarction. Since Russia eplerenone pharmacoeconomics issues rarely discussed, the analysis of the literature on this topic was performed. 2 studies examined effects of...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
«SILICEA-POLIGRAF» LLC
2015-08-01
|
| Seri Bilgileri: | Кардиоваскулярная терапия и профилактика |
| Konular: | |
| Online Erişim: | https://cardiovascular.elpub.ru/jour/article/view/251 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|